Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation

BackgroundPerioperative cardiac xenograft dysfunction (PCXD) describes a rapidly developing loss of cardiac function after xenotransplantation. PCXD occurs despite genetic modifications to increase compatibility of the heart. We report on the incidence of PCXD using static preservation in ice slush...

Full description

Bibliographic Details
Main Authors: Corbin E. Goerlich, Bartley Griffith, Avneesh K. Singh, Mohamed Abdullah, Shreya Singireddy, Irina Kolesnik, Billeta Lewis, Faith Sentz, Ivan Tatarov, Alena Hershfeld, Tianshu Zhang, Erik Strauss, Patrick Odonkor, Brittney Williams, Ali Tabatabai, Adnan Bhutta, David Ayares, David J. Kaczorowski, Muhammad M. Mohiuddin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.667093/full
id doaj-8e395806941043c1875d5057eb571ee2
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Corbin E. Goerlich
Corbin E. Goerlich
Bartley Griffith
Avneesh K. Singh
Mohamed Abdullah
Mohamed Abdullah
Shreya Singireddy
Irina Kolesnik
Billeta Lewis
Faith Sentz
Ivan Tatarov
Alena Hershfeld
Tianshu Zhang
Erik Strauss
Patrick Odonkor
Brittney Williams
Ali Tabatabai
Adnan Bhutta
David Ayares
David J. Kaczorowski
Muhammad M. Mohiuddin
spellingShingle Corbin E. Goerlich
Corbin E. Goerlich
Bartley Griffith
Avneesh K. Singh
Mohamed Abdullah
Mohamed Abdullah
Shreya Singireddy
Irina Kolesnik
Billeta Lewis
Faith Sentz
Ivan Tatarov
Alena Hershfeld
Tianshu Zhang
Erik Strauss
Patrick Odonkor
Brittney Williams
Ali Tabatabai
Adnan Bhutta
David Ayares
David J. Kaczorowski
Muhammad M. Mohiuddin
Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation
Frontiers in Immunology
xenotransplantation
graft dysfunction
cardiac xenotransplantation
cardiac preservation
heart transplant
heart failure
author_facet Corbin E. Goerlich
Corbin E. Goerlich
Bartley Griffith
Avneesh K. Singh
Mohamed Abdullah
Mohamed Abdullah
Shreya Singireddy
Irina Kolesnik
Billeta Lewis
Faith Sentz
Ivan Tatarov
Alena Hershfeld
Tianshu Zhang
Erik Strauss
Patrick Odonkor
Brittney Williams
Ali Tabatabai
Adnan Bhutta
David Ayares
David J. Kaczorowski
Muhammad M. Mohiuddin
author_sort Corbin E. Goerlich
title Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation
title_short Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation
title_full Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation
title_fullStr Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation
title_full_unstemmed Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation
title_sort blood cardioplegia induction, perfusion storage and graft dysfunction in cardiac xenotransplantation
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-06-01
description BackgroundPerioperative cardiac xenograft dysfunction (PCXD) describes a rapidly developing loss of cardiac function after xenotransplantation. PCXD occurs despite genetic modifications to increase compatibility of the heart. We report on the incidence of PCXD using static preservation in ice slush following crystalloid or blood-based cardioplegia versus continuous cold perfusion with XVIVO© heart solution (XHS) based cardioplegia.MethodsBaboons were weight matched to genetically engineered swine heart donors. Cardioplegia volume was 30 cc/kg by donor weight, with del Nido cardioplegia and the addition of 25% by volume of donor whole blood. Continuous perfusion was performed using an XVIVO © Perfusion system with XHS to which baboon RBCs were added.ResultsPCXD was observed in 5/8 that were preserved with crystalloid cardioplegia followed by traditional cold, static storage on ice. By comparison, when blood cardioplegia was used followed by cold, static storage, PCXD occurred in 1/3 hearts and only in 1/5 hearts that were induced with XHS blood cardioplegia followed by continuous perfusion. Survival averaged 17 hours in those with traditional preservation and storage, followed by 11.47 days and 15.03 days using blood cardioplegia and XHS+continuous preservation, respectively. Traditional preservation resulted in more inotropic support and higher average peak serum lactate 14.3±1.7 mmol/L compared to blood cardioplegia 3.6±3.0 mmol/L and continuous perfusion 3.5±1.5 mmol/L.ConclusionBlood cardioplegia induction, alone or followed by XHS perfusion storage, reduced the incidence of PCXD and improved graft function and survival, relative to traditional crystalloid cardioplegia-slush storage alone.
topic xenotransplantation
graft dysfunction
cardiac xenotransplantation
cardiac preservation
heart transplant
heart failure
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.667093/full
work_keys_str_mv AT corbinegoerlich bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT corbinegoerlich bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT bartleygriffith bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT avneeshksingh bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT mohamedabdullah bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT mohamedabdullah bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT shreyasingireddy bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT irinakolesnik bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT billetalewis bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT faithsentz bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT ivantatarov bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT alenahershfeld bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT tianshuzhang bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT erikstrauss bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT patrickodonkor bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT brittneywilliams bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT alitabatabai bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT adnanbhutta bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT davidayares bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT davidjkaczorowski bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
AT muhammadmmohiuddin bloodcardioplegiainductionperfusionstorageandgraftdysfunctionincardiacxenotransplantation
_version_ 1721388261348212736
spelling doaj-8e395806941043c1875d5057eb571ee22021-06-09T06:45:30ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-06-011210.3389/fimmu.2021.667093667093Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac XenotransplantationCorbin E. Goerlich0Corbin E. Goerlich1Bartley Griffith2Avneesh K. Singh3Mohamed Abdullah4Mohamed Abdullah5Shreya Singireddy6Irina Kolesnik7Billeta Lewis8Faith Sentz9Ivan Tatarov10Alena Hershfeld11Tianshu Zhang12Erik Strauss13Patrick Odonkor14Brittney Williams15Ali Tabatabai16Adnan Bhutta17David Ayares18David J. Kaczorowski19Muhammad M. Mohiuddin20Department of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Cardiothoracic Surgery, Cairo University, Cairo, EgyptDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Pediatrics, The University of Maryland School of Medicine, Baltimore, MD, United StatesRevivicor, Inc., Blacksburg, VA, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, MD, United StatesBackgroundPerioperative cardiac xenograft dysfunction (PCXD) describes a rapidly developing loss of cardiac function after xenotransplantation. PCXD occurs despite genetic modifications to increase compatibility of the heart. We report on the incidence of PCXD using static preservation in ice slush following crystalloid or blood-based cardioplegia versus continuous cold perfusion with XVIVO© heart solution (XHS) based cardioplegia.MethodsBaboons were weight matched to genetically engineered swine heart donors. Cardioplegia volume was 30 cc/kg by donor weight, with del Nido cardioplegia and the addition of 25% by volume of donor whole blood. Continuous perfusion was performed using an XVIVO © Perfusion system with XHS to which baboon RBCs were added.ResultsPCXD was observed in 5/8 that were preserved with crystalloid cardioplegia followed by traditional cold, static storage on ice. By comparison, when blood cardioplegia was used followed by cold, static storage, PCXD occurred in 1/3 hearts and only in 1/5 hearts that were induced with XHS blood cardioplegia followed by continuous perfusion. Survival averaged 17 hours in those with traditional preservation and storage, followed by 11.47 days and 15.03 days using blood cardioplegia and XHS+continuous preservation, respectively. Traditional preservation resulted in more inotropic support and higher average peak serum lactate 14.3±1.7 mmol/L compared to blood cardioplegia 3.6±3.0 mmol/L and continuous perfusion 3.5±1.5 mmol/L.ConclusionBlood cardioplegia induction, alone or followed by XHS perfusion storage, reduced the incidence of PCXD and improved graft function and survival, relative to traditional crystalloid cardioplegia-slush storage alone.https://www.frontiersin.org/articles/10.3389/fimmu.2021.667093/fullxenotransplantationgraft dysfunctioncardiac xenotransplantationcardiac preservationheart transplantheart failure